[TVTX] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
26-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -71.90%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 227,490 198,321 175,338 164,246 154,937 133,591 99,892 14.68%
PBT -179,682 -188,790 -146,448 -101,867 -58,363 -57,582 105,467 -
Tax 409 -19,359 -21 811 1,368 -9,679 -11,770 -
NP -180,091 -169,431 -146,427 -102,678 -59,731 -47,903 117,237 -
Tax Rate - - - - - - 11.16% -
Total Cost 407,581 367,752 321,765 266,924 214,668 181,494 -17,345 -
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -79.16 -85.43 -83.51 -62.51 -38.55 -35.86 117.36 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -3.01 -3.56 -3.46 -2.54 -1.54 -1.29 3.49 -
EPS Diluted -3.01 -3.56 -3.46 -2.54 -1.54 -1.25 3.17 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.